PPI-2458

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NamePPI-2458
Drug Alias NameMetaproPPI-2458NSC-720735
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionMethionine aminopeptidase 2 inhibitors
TargetsMethionine aminopeptidase 2
Therapy Area/IndicationsSolid tumoursLymphoma, Non-Hodgkin
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPraecis Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursLymphoma, Non-Hodgkin

Other Information

ATC CodeN/A
Related LinksN/A